- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06627686
Predictive Value of Airway Occlusion Pressure, Maximal Inspiratory Pressure and Their Ratio for Successful Extubation in Patients With Traumatic Brain Injury
Predictive Value of Airway Occlusion Pressure, Maximal Inspiratory Pressure and Their Ratio for Successful Extubation in Patients With Traumatic Brain Injury Observational Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Before spontaneous breathing trials with a T-piece for 30 min with an FIO2 of 0.40, measurements will be performed for a 20-second period. Three parameters will be analyzed: PImax, P0.1, and P0.1/PImax. PImax and P0.1 will be obtained using a unidirectional valve method and a manovacuometer (Instrumentation Industries, Bethel Park, PA) attached to the airway.
The device will have a scale of 30 cm H2O with a 1 cm H2O interval, and will be designed to perform measurements at each 0.1 second. Prior to testing, all subjects will be on pressure support ventilation mode (12-20 cm H2O) and will not be on sedatives. The head of the subject's bed will be elevated to 45 degrees and the cuff of the artificial airway will be hyperinflated to prevent air leakage during measurement.
The subject will have the airway clear of secretions by suctioning with standard tracheal suction procedures after pre-oxygenation for 2 minutes with FIO2 of 1.0.
After a brief rest period, pre-oxygenation will be repeated. The subject will then be disconnected from mechanical ventilation and allowed to breathe spontaneously for 10 seconds before connecting the artificial airway to the manovacuometer when the subject will at functional residual capacity. The subject will continuously be monitored by pulse oximetry and electrocardiogram, and will have continual respiratory physiotherapist attention.
For the present study, respiratory drive (P0.1) will be calculated as an average of the measured inspiratory pressure 0.1 s after the initiation of the inspiration for the first 3 cycles, and P0.1/PImax as the ratio of absolute values of P0.1 and PImax. The subjects will not coached for the maneuver. Thresholds for the 3 parameters will be calculated from their respective receiver operating characteristic (ROC) curves. Values more negative than -25 cm H2Owere used to predict successful weaning.
Weaning will be considered successful if spontaneous breathing will sustained for 48 hours after withdrawal from mechanical ventilation.
The trial will stopped if at least one of the following intolerance criteria present: SaO2 less than 90% or PaO2 less than 60 mm Hg with FIO2 greater than 0.4; PaCO2 greater than mm Hg or increased by 8 mm Hg or more; arterial pH less than 7.33 or decreased by 0.07 or more; respiratory rate greater than 35 breaths/ min or increased by 50% for 5 min or longer; heart rate greater than 140 beats/min or a sustained increase or decrease in 20%; mean blood pressure greater than 130mmHg or less than 70mmHg; or presence of agitation, diaphoresis, disorientation, or depressed mental status.
The subjects who will demonstrate one of these signs during the spontaneous breathing trial or within 48 hours after the discontinuation from mechanical ventilation will be considered not weaned and will returne to ventilator support.
Before being submitted to spontaneous breathing trials (SBTs) of 2 hours patients will have the tracheal P 0.1 and the PImax measured; P 0.1/PImax ratio will then be calculated.
Traditional thresholds will be adopted for the 3 parameters. Tracheal P 0.1 will be measured in pressure support ventilation, with pressure support in 7 cm H2O and positive end expiratory pressure in 5 cm H2O. At least 3 measurements, separated by an interval of not less than 15 seconds, will be obtained, and the mean value will be used for analysis. Tracheal P 0.1 values less than 4.2 cm H2O will be used to predict successful weaning.
P 0.1/PImax ratio will be obtained through the division of tracheal P 0.1 by PImax, and because both of them, in reality, are negative pressures, the result will expressed in positive values. Values smaller than 0.14 will be used to predict successful weaning.
4- Patients who will pass SBT without deterioration will extubated and receive oxygen through Venturi mask 40%. However, SBT failure will be considered if the patient develop a decreased level of consciousness, diaphoresis, RR>35 breaths/min, hemodynamic instability (heart rate>140, systolic blood pressure>180 or <90 mmHg) or signs of increased work of breathing.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ali Rashad, MBBCH
- Phone Number: 201018020543
- Email: draliali123456@gmail.com
Study Locations
-
-
Mahala
-
Tanta, Mahala, Egypt, 13821
- Recruiting
- Ali Rashad Ahmed
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Traumatic brain injury (closed type) patients who will be admitted to ICU and intubated and MV more than 24 hours will be included in this study.
Age from 18 to 65 years (male or female).
Fulfillment of Criteria of readiness for weaning off MV :
Resolution of the cause of respiratory insufficiency and MV. Stable hemodynamic profile
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Traumatic brain injury
Air way occlusion pressure and maximum inspiratory pressure
|
Predictive Value of Airway Occlusion Pressure, Maximal Inspiratory Pressure and Their Ratio for Successful Extubation in Patients with Traumatic Brain Injury
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sensetivity, specifity, predictive values, and accuracy of Maximal inspiratory pressure, Airway occlusion pressure and their ratio will be determined by ROC curve.
Time Frame: One day
|
One day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ali Rashad, MBBCH, Benha University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MS 23_7_2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weaning Failure
-
National Cancer Institute, EgyptCompletedWeaning Failure | Successful WeaningEgypt
-
Hospital do CoracaoNot yet recruitingWeaning Failure | Weaning From Mechanical Ventilation | Weaning From Mechanical Ventilation, Extubation
-
Cairo UniversityCompletedWeaning Failure | Weaning From Mechanical Ventilation | Mechanical VentilationEgypt
-
Ain Shams UniversityUnknown
-
Beni-Suef UniversityUnknown
-
Ain Shams UniversityCompleted
-
Cairo UniversityCompleted
-
Hôpital d'enfants Béchir-HamzaUnknownWeaning FailureTunisia
-
Hospital Israelita Albert EinsteinCompletedWeaning FailureBrazil
Clinical Trials on Air way occlusion pressure
-
Mansoura UniversityRecruiting
-
Riphah International UniversityCompletedPost-cardiac SurgeryPakistan
-
Assiut UniversityCompletedAcute Cardiogenic Pulmonary EdemaEgypt
-
Milton S. Hershey Medical CenterRecruiting
-
University of ValenciaNot yet recruiting
-
The Methodist Hospital Research InstituteActive, not recruitingLimb Occlusion PressureUnited States
-
Clinica Olivos SMGHospital Nacional Profesor Alejandro PosadasCompletedHealthy VolunteersArgentina
-
University of FreiburgRecruitingIndication for CSF Dynamic Testing | Indication for CSF Infusion TestGermany
-
University of SurreyCompletedMuscle Soreness | Muscle Strength | Muscle DamageUnited Kingdom
-
Beni-Suef UniversityUnknown